中国临床药理学杂志2018，Vol.34Issue(20)：2461-2464,4.DOI:10.13699/j.cnki.1001-6821.2018.20.019
糖尿病常用药与骨折风险关联性的研究进展
Research progress in the correlation between diabetic drug and fracture risk
摘要
Abstract
Diabetes mellitus ( DM) is a metabolic disease characterized by hyperglycemia.Sustained hyperglycemia can lead to many complica-tions such as: retina, kidney, nervous system lesions, vascular compli-cations and fractures.As China gradually enters an aging society , the number of patients suffering from DM and fractures has increased signifi-cantly.In recent years, through continuous research and exploration of commonly used drugs for diabetes by scholars at home and abroad , the link between commonly used drugs for diabetes and fracture risk has been gradually recognized.This article focused on the latest development in the study of the association between fracture risk and commonly used drugs for diabetes such as thiazolidinediones , sodium -glucose co -transporter 2 inhibitors, sulfonylureas, metformin drugs, insulin, incre-tins, and dipeptidyl peptidase -4 inhibitors.关键词
糖尿病/并发症/药物/骨折Key words
diabetes/complication/drug/fracture分类
医药卫生引用本文复制引用
赵磊,何晓静,菅凌燕..糖尿病常用药与骨折风险关联性的研究进展[J].中国临床药理学杂志,2018,34(20):2461-2464,4.基金项目
辽宁省自然科学基金资助项目(2014021090) （2014021090）
